DIM
DC Investments Management Portfolio holdings
AUM
$240M
This Quarter Return
+4.21%
1 Year Return
+17.11%
3 Year Return
+33.53%
5 Year Return
+148.92%
10 Year Return
–
AUM
$157M
AUM Growth
+$157M
(+5.5%)
Cap. Flow
+$6.29M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
6.71%
Holding
424
New
174
Increased
42
Reduced
68
Closed
139
Top Buys
| 1 |
Evergy
EVRG
|
$1.14M |
| 2 |
AerCap
AER
|
$868K |
| 3 |
Inspire Medical Systems
INSP
|
$857K |
| 4 |
Garmin
GRMN
|
$851K |
| 5 |
GSK
GSK
|
$821K |
Top Sells
| 1 |
Pfizer
PFE
|
$2.53M |
| 2 |
Amgen
AMGN
|
$2.11M |
| 3 |
Johnson & Johnson
JNJ
|
$1.63M |
| 4 |
Elevance Health
ELV
|
$1.56M |
| 5 |
Northrop Grumman
NOC
|
$1.55M |
Sector Composition
| 1 | Healthcare | 19.87% |
| 2 | Financials | 19.67% |
| 3 | Technology | 12.25% |
| 4 | Real Estate | 10.82% |
| 5 | Utilities | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cisco
CSCO
$274B
| $1.71M | 1.09% | 39,659 +3,233 | +9% | +$139K |
|
2
UnitedHealth
UNH
$281B
| $1.34M | 0.85% | 5,466 -5,740 | -51% | -$1.41M |
|
|
3
Evergy
EVRG
$16.4B
| $1.14M | 0.73% | +20,319 | New | +$1.14M |
|
4
Allstate
ALL
$53.6B
| $1.08M | 0.69% | 11,878 +612 | +5% | +$55.9K |
|
5
Steris
STE
$24.1B
| $923K | 0.59% | 8,794 +4,969 | +130% | +$522K |
|
6
Accenture
ACN
$162B
| $902K | 0.57% | 5,516 +3,249 | +143% | +$531K |
|
7
Aflac
AFL
$57.2B
| $877K | 0.56% | 20,390 +3,447 | +20% | +$148K |
|
|
8
AerCap
AER
$22B
| $868K | 0.55% | +16,024 | New | +$868K |
|
|
9
Inspire Medical Systems
INSP
$2.77B
| $857K | 0.55% | +24,019 | New | +$857K |
|
|
RDS.A
10
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $854K | 0.54% | 12,340 +7,084 | +135% | +$490K |
|
|
11
Garmin
GRMN
$46.5B
| $851K | 0.54% | +13,950 | New | +$851K |
|
12
Goldman Sachs
GS
$226B
| $848K | 0.54% | 3,844 +817 | +27% | +$180K |
|
13
TotalEnergies
TTE
$137B
| $838K | 0.53% | 13,832 +9,989 | +260% | +$605K |
|
14
ENI
E
$53.8B
| $826K | 0.53% | 22,242 +12,086 | +119% | +$449K |
|
|
15
GSK
GSK
$79.9B
| $821K | 0.52% | +20,362 | New | +$821K |
|
16
Smith & Nephew
SNN
$16.3B
| $814K | 0.52% | +21,692 | New | +$814K |
|
17
Fresenius Medical Care
FMS
$15.1B
| $812K | 0.52% | 16,128 +9,590 | +147% | +$483K |
|
18
Abbott
ABT
$231B
| $805K | 0.51% | 13,195 +4,407 | +50% | +$269K |
|
19
Colgate-Palmolive
CL
$67.9B
| $793K | 0.5% | 12,230 +6,658 | +119% | +$432K |
|
20
NXP Semiconductors
NXPI
$59.2B
| $788K | 0.5% | 7,208 +1,857 | +35% | +$203K |
|
21
TE Connectivity
TEL
$61B
| $765K | 0.49% | 8,494 +5,791 | +214% | +$522K |
|
22
Novo Nordisk
NVO
$251B
| $760K | 0.48% | 16,486 +10,757 | +188% | +$496K |
|
23
Charles Schwab
SCHW
$174B
| $738K | 0.47% | +14,449 | New | +$738K |
|
|
PS
24
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $734K | 0.47% | +30,000 | New | +$734K |
|
25
Stifel
SF
$11.8B
| $730K | 0.46% | +13,970 | New | +$730K |
|